Patent details

EP3137621 Title: MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS

Basic Information

Publication number:
EP3137621
PCT Application Number:
GB2015051250
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157210279
PCT Publication Number:
WO2015166242
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS
French Title of Invention:
FABRICATION DE NEUROTOXINES CLOSTRIDIUM BOTULINUM DE RECOMBINAISON
German Title of Invention:
HERSTELLUNG VON REKOMBINANTEN CLOSTRIDIUM-BOTULINUM-NEUROTOXINEN
SPC Number:

Dates

Filing date:
29/04/2015
Grant date:
17/07/2019
EP Publication Date:
08/03/2017
PCT Publication Date:
05/11/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/07/2019
EP B1 Publication Date:
17/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/04/2020
Expiration date:
29/04/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/07/2019
 
 

Name:
Ipsen Bioinnovation Limited
Address:
102 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom (GB)

Inventor

1

Name:
PALAN, Shilpa
Address:
United Kingdom (GB)

2

Name:
LIU, Sai Man
Address:
United Kingdom (GB)

3

Name:
HACKETT, Gavin Stephen
Address:
United Kingdom (GB)

Priority

Priority Number:
201407525
Priority Date:
29/04/2014
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 38/48; C12P 21/06;

Publication

European Patent Bulletin

Issue number:
201929
Publication date:
17/07/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages